TRIDIHEXETHYL CHLORIDE (200 MG)
- Product Name
- TRIDIHEXETHYL CHLORIDE (200 MG)
- CAS No.
- 4310-35-4
- Chemical Name
- TRIDIHEXETHYL CHLORIDE (200 MG)
- Synonyms
- Pathilon;tridihexethyl chloride;Propethonum;pathilonchloride;XJGONMZLEDGBRM-UHFFFAOYSA-N;TRIDIHEXETHYL CHLORIDE (200 MG);Tridihexethyl Chloride (1683005);(3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethylammoniumchloride;(3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethyl-ammoniuchloride;gamma-cyclohexyl-n,n,n-triethyl-gamma-hydroxy-benzenepropanaminiuchlorid
- CBNumber
- CB3501412
- Molecular Formula
- C21H35ClNO
- Formula Weight
- 352.9617
- MOL File
- 4310-35-4.mol
N-Bromosuccinimide Price
- Product number
- T775050
- Product name
- TridihexethylChloride
- Packaging
- 25mg
- Price
- $185
- Updated
- 2021/12/16
- Product number
- 62295
- Product name
- TridihexethylChloride
- Packaging
- 5mg
- Price
- $290
- Updated
- 2021/12/16
- Product number
- CHM0309851
- Product name
- TRIDIHEXETHYL CHLORIDE
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $496.84
- Updated
- 2021/12/16
TRIDIHEXETHYL CHLORIDE (200 MG) Chemical Properties,Usage,Production
Uses
Tridihexethyl Chloride, is an anticholinergic, antimuscarinic and antispasmodic drug.
Definition
ChEBI: Tridihexethyl chloride is an organic chloride salt. It contains a tridihexethyl.
brand name
Pathilon (Lederle).
General Description
Tridihexethyl chloride,3-cyclohexyl-3-hydroxy-3-phenylpropyl)triethylammoniumchloride (Pathilon), is a white, bitter, crystalline powderwith a characteristic odor. The compound is freely soluble inwater and alcohol, with aqueous solutions being nearly neutralin reaction.
Although this drug, introduced in 1958, has ganglionblockingactivity, its peripheral atropine-like activity predominates;therefore, its therapeutic application has beenbased on the latter activity. It possesses the antispasmodicand the antisecretory activities characteristic of this group,but because of its quaternary character, it is valueless in relievingParkinson syndrome.
Clinical Use
tridihexethyl chloride is useful for adjunctive therapy in a wide varietyof GI diseases, such as peptic ulcer, gastric hyperacidity,and hypermotility and spastic conditions, such as spasticcolon, functional diarrhea, pylorospasm, and other relatedconditions. Because its action is predominantly antisecretory,it is more effective in gastric hypersecretion than in hypermotilityand spasm. It is best administered intravenouslyfor the latter conditions.
The side effects usually found with effective anticholinergictherapy occur with the use of this drug. These are drynessof mouth, mydriasis, and such. As with other anticholinergics,care should be exercised when administering the drug topatients with glaucomatous conditions, cardiac decompensation,and coronary insufficiency. It is contraindicated inpatients with obstruction at the bladder neck, prostatic hypertrophy,stenosing gastric and duodenal ulcers, or pyloric orduodenal obstruction.